VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMW 2019 | Multiple myeloma MRD assessment

Prof Fengyan Jin of Jilin University, Jilin, China, outlines the issues with current criteria regarding (measurable residual disease) MRD testing within clinical trials, namely the depth of MRD sensitivity, which cannot always be reached, and the suggested duration of MRD. Recorded at the International Myeloma Workshop (IMW) 2019, in Boston, MA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter